Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+4.73%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
+$1.06B
(+2%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
30.64%
Holding
972
New
111
Increased
254
Reduced
428
Closed
112
Top Buys
| 1 |
HES
Hess
HES
|
$470M |
| 2 |
Exxon Mobil
XOM
|
$248M |
| 3 |
Hubbell
HUBB
|
$139M |
| 4 |
Costco
COST
|
$124M |
| 5 |
Chubb
CB
|
$117M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$281M |
| 2 |
Emerson Electric
EMR
|
$233M |
| 3 |
AbbVie
ABBV
|
$169M |
| 4 |
Amazon
AMZN
|
$167M |
| 5 |
RB Global
RBA
|
$165M |
Sector Composition
| 1 | Technology | 29.07% |
| 2 | Healthcare | 16.38% |
| 3 | Financials | 10.36% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Industrials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Labcorp
LH
$22.9B
| $4.25M | 0.01% |
+20,900
| New | +$4.25M |
|
727
Phillips Edison & Co
PECO
$4.53B
| $4.09M | 0.01% |
+125,000
| New | +$4.09M |
|
|
VZIO
728
DELISTED
VIZIO Holding Corp.
VZIO
| $4.09M | 0.01% |
378,489
-221,511
| -37% | -$2.39M |
|
729
Mattel
MAT
$6.01B
| $4.07M | 0.01% |
+250,000
| New | +$4.07M |
|
730
Fox Class B
FOX
$24.6B
| $4.05M | 0.01% |
126,565
-1,600
| -1% | -$51.2K |
|
|
LAC
731
Lithium Americas
LAC
$674M
| $4.02M | 0.01% |
+1,500,000
| New | +$4.02M |
|
732
Essex Property Trust
ESS
$17B
| $3.97M | 0.01% |
14,600
-48,400
| -77% | -$13.2M |
|
|
AMED
733
DELISTED
Amedisys
AMED
| $3.92M | 0.01% |
+42,664
| New | +$3.92M |
|
734
Perspective Therapeutics
CATX
$263M
| $3.8M | 0.01% |
+381,640
| New | +$3.8M |
|
735
JFrog
FROG
$5.65B
| $3.76M | 0.01% |
100,000
-15,000
| -13% | -$563K |
|
736
Karyopharm Therapeutics
KPTI
$58.4M
| $3.75M | 0.01% |
287,989
+54,656
| +23% | +$711K |
|
737
CytomX Therapeutics
CTMX
$346M
| $3.66M | 0.01% |
3,000,000
+1,000,000
| +50% | +$1.22M |
|
|
LADR
738
Ladder Capital
LADR
$1.5B
| $3.61M | 0.01% |
320,000
-505,000
| -61% | -$5.7M |
|
739
Ormat Technologies
ORA
$5.54B
| $3.59M | 0.01% |
+50,000
| New | +$3.59M |
|
|
RGLS
740
DELISTED
Regulus Therapeutics
RGLS
| $3.57M | 0.01% |
2,000,000
-1,679,854
| -46% | -$3M |
|
741
Olema Pharmaceuticals
OLMA
$436M
| $3.52M | 0.01% |
325,000
-135,000
| -29% | -$1.46M |
|
|
SQSP
742
DELISTED
Squarespace, Inc.
SQSP
| $3.51M | 0.01% |
+80,558
| New | +$3.51M |
|
743
Icon
ICLR
$13.7B
| $3.45M | 0.01% |
11,000
-3,000
| -21% | -$940K |
|
744
AtriCure
ATRC
$1.77B
| $3.42M | 0.01% |
+150,000
| New | +$3.42M |
|
745
Century Therapeutics
IPSC
$41.4M
| $3.37M | 0.01% |
+1,322,751
| New | +$3.37M |
|
|
SMAR
746
DELISTED
Smartsheet Inc.
SMAR
| $3.31M | 0.01% |
+75,000
| New | +$3.31M |
|
747
Travere Therapeutics
TVTX
$1.89B
| $3.29M | 0.01% |
400,000
-100,000
| -20% | -$822K |
|
748
Kimbell Royalty Partners
KRP
$1.28B
| $3.27M | 0.01% |
200,000
| – | – |
|
749
89bio
ETNB
$1.28B
| $3.2M | 0.01% |
400,000
-50,000
| -11% | -$401K |
|
750
Match Group
MTCH
$9B
| $3.18M | 0.01% |
104,816
-61,800
| -37% | -$1.88M |
|